Venturi Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.2M | Buy |
100,019
+1,100
| +1% | +$237K | 0.97% | 26 |
|
|
2026
Q1 | $21.5M | Buy |
98,919
+8,611
| +10% | +$1.91M | 0.97% | 25 |
|
|
2025
Q4 | $20.6M | Buy |
90,308
+915
| +1% | +$208K | 0.92% | 27 |
|
|
2025
Q3 | $20.7M | Sell |
89,393
-372
| -0.4% | -$75.8K | 0.96% | 27 |
|
|
2025
Q2 | $16.7M | Buy |
89,765
+389
| +0.4% | +$72.3K | 0.82% | 36 |
|
|
2025
Q1 | $18.7M | Buy |
89,376
+10,620
| +13% | +$2.06M | 0.97% | 22 |
|
|
2024
Q4 | $14M | Buy |
78,756
+892
| +1% | +$164K | 0.69% | 39 |
|
|
2024
Q3 | $15.4M | Buy |
77,864
+5,993
| +8% | +$1.12M | 0.8% | 33 |
|
|
2024
Q2 | $12.3M | Buy |
71,871
+1,054
| +1% | +$175K | 0.73% | 40 |
|
|
2024
Q1 | $12.9M | Sell |
70,817
-3,134
| -4% | -$540K | 0.83% | 32 |
|
|
2023
Q4 | $11.5M | Buy |
73,951
+3,702
| +5% | +$540K | 0.81% | 34 |
|
|
2023
Q3 | $10.5M | Buy |
70,249
+63,102
| +883% | +$9.26M | 0.82% | 27 |
|
|
2023
Q2 | $963K | Buy |
7,147
+429
| +6% | +$62.9K | 0.08% | 162 |
|
|
2023
Q1 | $1.07M | Sell |
6,718
-945
| -12% | -$144K | 0.09% | 147 |
|
|
2022
Q4 | $1.24M | Buy |
7,663
+90
| +1% | +$13.8K | 0.11% | 127 |
|
|
2022
Q3 | $1.02M | Sell |
7,573
-775
| -9% | -$111K | 0.1% | 135 |
|
|
2022
Q2 | $1.28M | Buy |
8,348
+100
| +1% | +$15.3K | 0.11% | 109 |
|
|
2022
Q1 | $1.34M | Sell |
8,248
-864
| -9% | -$126K | 0.1% | 113 |
|
|
2021
Q4 | $1.23M | Buy |
9,112
+787
| +9% | +$93K | 0.09% | 136 |
|
|
2021
Q3 | $898K | Buy |
8,325
+243
| +3% | +$27.8K | 0.07% | 173 |
|
|
2021
Q2 | $910K | Sell |
8,082
-19
| -0.2% | -$2.14K | 0.08% | 164 |
|
|
2021
Q1 | $877K | Sell |
8,101
-277
| -3% | -$29.6K | 0.08% | 165 |
|
|
2020
Q4 | $898K | Buy |
8,378
+783
| +10% | +$75.2K | 0.09% | 155 |
|
|
2020
Q3 | $665K | Buy |
7,595
+304
| +4% | +$28.6K | 0.08% | 170 |
|
|
2020
Q2 | $716K | Buy |
7,291
+2,273
| +45% | +$200K | 0.1% | 134 |
|
|
2020
Q1 | $382K | Buy |
+5,018
| New | +$427K | 0.07% | 144 |
|
|
2019
Q3 | – | Sell |
-4,240
| Closed | -$308K | – | 227 |
|
|
2019
Q2 | $308K | Sell |
4,240
-88,524
| -95% | -$6.96M | 0.04% | 197 |
|
|
2019
Q1 | $7.49M | Buy |
92,764
+23,246
| +33% | +$1.9M | 0.97% | 39 |
|
|
2018
Q4 | $6M | Buy |
69,518
+1,320
| +2% | +$116K | 0.97% | 29 |
|
|
2018
Q3 | $6.48M | Buy |
68,198
+1,223
| +2% | +$116K | 1.15% | 33 |
|
|
2018
Q2 | $6.39M | Sell |
66,975
-1,101
| -2% | -$108K | 1.19% | 31 |
|
|
2018
Q1 | $6.44M | Sell |
68,076
-16,359
| -19% | -$1.8M | 1.24% | 18 |
|
|
2017
Q4 | $8.17M | Sell |
84,435
-4,369
| -5% | -$412K | 1.56% | 11 |
|
|
2017
Q3 | $8.03M | Sell |
88,804
-12,470
| -12% | -$949K | 1.7% | 8 |
|
|
2017
Q2 | $7.34M | Sell |
101,274
-15,638
| -13% | -$1.05M | 1.67% | 8 |
|
|
2017
Q1 | $7.44M | Buy |
116,912
+8,627
| +8% | +$542K | 1.72% | 13 |
|
|
2016
Q4 | $6.78M | Buy |
108,285
+6,520
| +6% | +$398K | 1.91% | 13 |
|
|
2016
Q3 | $6.42M | Buy |
101,765
+5,560
| +6% | +$360K | 2.13% | 10 |
|
|
2016
Q2 | $5.96M | Buy |
96,205
+82,205
| +587% | +$5.01M | 2.02% | 11 |
|
|
2016
Q1 | $800K | Hold |
14,000
| – | – | 0.3% | 81 |
|
|
2015
Q4 | $829K | Buy |
+14,000
| New | +$806K | 0.38% | 72 |
|
Other funds holding ABBV
Venturi Wealth Management's ABBV Position: Q2 2026 in Review
Venturi Wealth Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $237K and bringing the position to 100,019 shares worth $25.2M. The position accounts for 0.97% of the portfolio, ranked #26.
Venturi Wealth Management first reported a position in ABBV in Q4 2015 and has held it in 41 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Venturi Wealth Management held 100,019 shares of AbbVie worth $25.2M as of Q2 2026.
- Venturi Wealth Management bought 1,100 AbbVie shares in Q2 2026, an estimated $237K.
- AbbVie made up 0.97% of Venturi Wealth Management's portfolio in Q2 2026, its #26 holding.
- Venturi Wealth Management first reported a position in AbbVie in Q4 2015 and has held it in 41 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.